Background Library
We offer you detailed press kits with a lot of background information, downloads, and contacts.
Topics
| Company | Personalised healthcare | Virology |
| Diabetes | Research & Development | |
| Oncology | Rheumatoid arthritis |
In Focus: Oncology
Bevacizumab, the antibody in the anti-tumour drug Avastin
The Roche Group is the world’s leading provider of cancer care products. Our anti-cancer medicines are saving lives and significantly advancing the way some cancers are treated. The Roche portfolio currently includes five innovative cancer products proven to provide survival benefit in a number of different tumor types: Avastin® (bevacizumab), Herceptin® (trastuzumab), Xeloda® (capecitabine), MabThera® (rituximab) and Tarceva® (erlotinib).
more